Sectors & IndustriesHealthcareMedical Instruments & Supplies

Best Medical Stocks to Buy Now (2022)

Top medical stocks in 2022 ranked by overall Zen Score. See the best medical stocks to buy now, according to analyst forecasts for the medical instruments & supplies industry.

According to Zen Score, the 3 best medical stocks to buy right now are:

Staar Surgical Co (NASDAQ:STAA) is the top medical stock with a Zen Score of 74, which is 38 points higher than the medical industry average of 36. It passed 25 out of 33 due diligence checks and has strong fundamentals. Staar Surgical Co has seen its stock lose -42.86% over the past year, underperforming other medical stocks by -12 percentage points.

Staar Surgical Co has an average 1 year price target of $107.80, an upside of 50.03% from Staar Surgical Co's current stock price of $71.85.

Staar Surgical Co stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Staar Surgical Co, 80% have issued a Strong Buy rating, 20% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

West Pharmaceutical Services (NYSE:WST) is the second best medical stock with a Zen Score of 63, which is 27 points higher than the medical industry average of 36. It passed 24 out of 38 due diligence checks and has strong fundamentals. West Pharmaceutical Services has seen its stock lose -41.89% over the past year, underperforming other medical stocks by -11 percentage points.

West Pharmaceutical Services has an average 1 year price target of $400.00, an upside of 59.19% from West Pharmaceutical Services's current stock price of $251.27.

West Pharmaceutical Services stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering West Pharmaceutical Services, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Repligen (NASDAQ:RGEN) is the third best medical stock with a Zen Score of 59, which is 23 points higher than the medical industry average of 36. It passed 20 out of 33 due diligence checks and has strong fundamentals. Repligen has seen its stock lose -33.24% over the past year, underperforming other medical stocks by -3 percentage points.

Repligen has an average 1 year price target of $249.50, an upside of 30.59% from Repligen's current stock price of $191.06.

Repligen stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Repligen, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 11 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

Utah Medical Products (NASDAQ:UTMD) has an annual dividend yield of 3.31%, which is 2 percentage points higher than the medical industry average of 1.25%. Utah Medical Products's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Utah Medical Products's dividend has shown consistent growth over the last 10 years.

Utah Medical Products's dividend payout ratio of 65.4% indicates that its dividend yield is sustainable for the long-term.

Baxter International (NYSE:BAX) has an annual dividend yield of 2.06%, which is 1 percentage points higher than the medical industry average of 1.25%. Baxter International's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Baxter International's dividend has not shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of 55.9% indicates that its dividend yield is sustainable for the long-term.

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 1.66%, which is the same as the medical industry average of 1.25%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of 22.3% indicates that its dividend yield is sustainable for the long-term.

Medical stocks were down -0.58% in the last day, and down -0.89% over the last week. Isoray was the among the top losers in the medical instruments & supplies industry, dropping -27.39% yesterday.

IsoRay shares are trading lower after the company announced it entered into a definitive agreement to acquire Viewpoint Molecular Targeting.

Based on WallStreetZen's Valuation Score, the 3 most undervalued medical stocks right now are:

Utah Medical Products (NASDAQ:UTMD) is the most undervalued medical stock based on WallStreetZen's Valuation Score. Utah Medical Products has a valuation score of 71, which is 40 points higher than the medical industry average of 31. It passed 5 out of 7 valuation due diligence checks.

Utah Medical Products's stock has dropped -10.02% in the past year. It has overperformed other stocks in the medical industry by 21 percentage points.

Meihua International Medical Technologies Co (NASDAQ:MHUA) is the second most undervalued medical stock based on WallStreetZen's Valuation Score. Meihua International Medical Technologies Co has a valuation score of 71, which is 40 points higher than the medical industry average of 31. It passed 5 out of 7 valuation due diligence checks.

Dentsply Sirona (NASDAQ:XRAY) is the third most undervalued medical stock based on WallStreetZen's Valuation Score. Dentsply Sirona has a valuation score of 71, which is 40 points higher than the medical industry average of 31. It passed 5 out of 7 valuation due diligence checks.

Dentsply Sirona's stock has dropped -50.11% in the past year. It has underperformed other stocks in the medical industry by -20 percentage points.